FindMyKOL

Alexandra Kimball, MD, MPH

Enriched profile

President and CEO, Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center · Beth Israel Deaconess Medical Center

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyDermatologyFocusAcne / Hidradenitis+9
Active KOLFindMyKOL type: EliteLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Alexandra Kimball is President and CEO, Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center at Beth Israel Deaconess Medical Center. ClinicalTrials.gov lists 14 registered studies with this person as an investigator.

Data verified 27 Oct 2026

Overview

Updated 2 Nov 2026

Alexa B. Kimball, MD MPH, is President and CEO, Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 20 companies.

  • Top research focus: Acne / Hidradenitis
  • 14 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 2 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Acne / Hidradenitis4 trialsPsoriasis / Psoriatic Arthritis2 trialsAcne Vulgaris2 trialsHidradenitis Suppurativa2 trialsLymphadenitis2 trialsPemphigus1 trialPsoriasis (Derm)1 trialCarcinoma, Squamous Cell1 trialSkin Neoplasms1 trialBasal Cell Carcinoma1 trialHerpes Labialis1 trialLichen Planus1 trialObesity1 trialHypertension1 trialDyslipidemia / Lipid Disorders1 trialMetabolic Syndrome1 trialVitiligo1 trialAtopic Dermatitis / Eczema1 trialEczema1 trial

Research focus

OpenAlex concept fingerprint
Acne / HidradenitisAcne VulgarisHidradenitis SuppurativaAtopic Dermatitis / EczemaEczemaHerpes LabialisLichen PlanusPemphigusPsoriasis (Derm)Vitiligo

Drugs & molecules

across trials, industry payments and publications
Dupixentgeneric · DupilumabClinical trials—Industry payments32Publications—Bimzelxgeneric · BimekizumabClinical trials—Industry payments15Publications—Spevigogeneric · SpesolimabClinical trials—Industry payments12Publications—Cosentyxgeneric · SecukinumabClinical trials—Industry payments8Publications—Remicadegeneric · InfliximabClinical trials—Industry payments8Publications—Skyrizigeneric · RisankizumabClinical trials—Industry payments3Publications—Humirageneric · AdalimumabClinical trials—Industry payments2Publications—Olumiantgeneric · BaricitinibClinical trials—Industry payments2Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments2Publications—Cibinqogeneric · AbrocitinibClinical trials—Industry payments1Publications—Ofevgeneric · NintedanibClinical trials—Industry payments1Publications—Rhapsidogeneric · RemibrutinibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments41Incyte CorporationClinical trials—Industry payments40Genzyme CorporationClinical trials—Industry payments30Almirall LLCClinical trials—Industry payments28Eli Lilly and CompanyClinical trials—Industry payments28Boehringer Ingelheim International GmbHClinical trials—Industry payments26Novartis Pharmaceuticals CorporationClinical trials—Industry payments23Sanofi-Aventis U.S. LLCClinical trials—Industry payments15Janssen Global Services, LLCClinical trials—Industry payments14UCB, Inc.Clinical trials—Industry payments14Massachusetts General HospitalClinical trials10Industry payments—Janssen Scientific Affairs, LLCClinical trials—Industry payments9Ucb SaClinical trials—Industry payments9Merck Sharp & Dohme LLCClinical trials—Industry payments7Pfizer Inc.Clinical trials—Industry payments7Sanofi Us Services Inc.Clinical trials—Industry payments6Novartis Pharma AGClinical trials—Industry payments4NeoStrata Company, Inc.Clinical trials2Industry payments—Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments2Beth Israel Deaconess Medical CenterClinical trials1Industry payments—E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Janssen Biotech, Inc.Clinical trials—Industry payments1Moe Medical DevicesClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
0citations

Total citations across indexed works.

0h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 2 Nov 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 2 Nov 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    84.6%
    TNF inhibitor30.8%
    Humira(Cf) Pen78%Remicade22%
    Part D<11 patients
    Interleukin inhibitors16.4%
    Bimzelx Autoinjector100%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    9.2%
    Aldosterone antagonist (MRA)9.2%
    Spironolactone100%
    Part D<11 patients
  • Dermatology

    6.2%
    Interleukin-4 Receptor alpha Antagonist6.2%
    Dupixent Pen100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 2 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/alexandra-kimball-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    meetings-external.aad.org/AM2026/Speakers/Details/28483

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →meetings-external.aad.org ↗
  • Other

    psoriasiscouncil.org/people/alexa-kimball

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasiscouncil.org ↗
  • Other

    research.bidmc.org/alexa-kimball/people/team-member-1

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.bidmc.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 2 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Yale

    1994
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
  • MPH

    Johns Hopkins

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.